Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1023879 | 0.96 | F10 (0.75) | F10F2 | |
| SCHEMBL20371719 | 0.89 | F10 (0.79) | F10F2 | |
| SCHEMBL13232280 | 0.85 | F10 (0.81) | F10F2 | |
| SCHEMBL4961986 | 0.85 | F10 (0.73) | F10 | |
| SCHEMBL4956633 | 0.85 | F10 (0.68) | F10 | |
| SCHEMBL4960100 | 0.85 | F10 (0.72) | F10 | |
| SCHEMBL9288947 | 0.85 | F10 (0.72) | F10 | |
| SCHEMBL28410087 | 0.84 | F10 (0.89) | F10F2 | |
| SCHEMBL1025433 | 0.84 | F10 (0.89) | F10F2 | |
| SCHEMBL8244907 | 0.84 | F10 (0.74) | F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1945634-B1 | PHENYLENEBISOXAZOLIDINE DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | BAYER SCHERING PHARMA AG (DE) | 2011-01-19 | — | — | EP | disclosed |
| US-20100041646-A1 | Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants | BAYER HEALTHCARE AG (DE) | 2010-02-18 | — | — | US | disclosed |
| US-20100041646-A1 | Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants | BAYER HEALTHCARE AG (DE) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041646-A1 | Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants | SELP, SERPINC1, F2 | F10 346/4885F2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.